GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)

BOM:500660 Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	11,465	10,360	9,276	5,900	6,107	16,947
Depreciation & Amortization	575.79	596.69	565.7	591.43	560.73	587.16
Other Amortization	67.75	67.75	102.22	105.37	96.94	94.7
Loss (Gain) From Sale of Assets	3.26	0.46	15.13	-8.89	-0.28	-3.24
Loss (Gain) From Sale of Investments	-872.4	-796.3	-696.5	-487.76	-307.79	-5.92
Provision & Write-off of Bad Debts	3.46	18.86	23.76	5.87	-73.64	1.62
Other Operating Activities	-848.11	-232.61	1,765	-895.67	-1,124	-11,442
Change in Accounts Receivable	-67.59	175.52	-728.68	-302.69	202.28	102.04
Change in Inventory	-184.58	241.82	433.11	-650.78	747.25	120.03
Change in Accounts Payable	750.14	-1,389	769.69	1,901	-1,532	1,024
Change in Other Net Operating Assets	-583.15	-10.45	1,374	-337.69	125.16	-47.1
Operating Cash Flow	10,314	9,033	12,899	5,820	4,842	8,107
Operating Cash Flow Growth	38.76%	-29.97%	121.63%	20.20%	-40.27%	40.29%

Investing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-649.39	-552.79	-230.22	-312.22	-440.39	-346.41
Sale of Property, Plant & Equipment	7.75	220.35	57.17	224.56	14.57	11.77
Sale (Purchase) of Real Estate	-	-	-	-	97.8	323.42
Investment in Securities	2,063	3,172	-1,444	-1,454	9,563	-18,124
Other Investing Activities	1,345	1,131	1,159	1,629	-1,156	14,080
Investing Cash Flow	2,766	3,970	-458.01	87.12	8,079	-4,055

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Long-Term Debt Repaid	-	-203.74	-187.31	-181.25	-168.68	-156.18
Lease Payments	-240.64	-203.74	-187.31	-181.25	-168.68	-155.94
Net Debt Issued (Repaid)	-240.64	-203.74	-187.31	-181.25	-168.68	-156.18
Common Dividends Paid	-9,699	-7,140	-7,494	-5,416	-15,255	-5,066
Other Financing Activities	-32.62	-27.32	-13.14	-17.99	-9.55	-19.9
Financing Cash Flow	-9,972	-7,371	-7,694	-5,615	-15,433	-5,242

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash Flow	3,108	5,632	4,747	292.3	-2,512	-1,190

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	9,664	8,480	12,669	5,508	4,402	7,761
Free Cash Flow Growth	34.40%	-33.06%	130.01%	25.13%	-43.28%	45.42%
Free Cash Flow Margin	23.02%	22.19%	33.79%	15.95%	13.54%	23.68%
Free Cash Flow Per Share	57.19	50.06	74.78	32.51	25.98	45.81
Levered Free Cash Flow	9,065	7,293	11,624	6,701	1,562	10,097
Unlevered Free Cash Flow	9,086	7,310	11,632	6,712	1,573	10,109
Free Cash Flow After Leases	9,424	8,276	12,481	5,327	4,233	7,605

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	27.32	27.32	13.14	17.99	13.98	17.37
Cash Income Tax Paid	3,216	3,216	823.79	2,349	2,646	1,195
Change in Working Capital	-81.37	-981.67	1,848	610.21	-457.46	1,199

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error